Titanium as a reconstruction and implant material in dentistry: advantages and pitfalls by Özcan, Mutlu & Hämmerle, Christoph
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2012
Titanium as a reconstruction and implant material in dentistry: advantages
and pitfalls
Özcan, Mutlu; Hämmerle, Christoph
Abstract: Commercial pure titanium (cpTi) has been the material of choice in several disciplines of den-
tistry due to its biocompatibility, resistance to corrosion and mechanical properties. Despite a number
of favorable characteristics, cpTi as a reconstruction and oral implant material has several shortcomings.
This paper highlights current knowledge on material properties, passive oxidation film formation, corro-
sion, surface activation, cell interactions, biofilm development, allergy, casting and machining properties
of cpTi for better understanding and potential improvement of this material for its clinical applications.
DOI: 10.3390/ma5091528
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-75472
Published Version
 
 
Originally published at:
Özcan, Mutlu; Hämmerle, Christoph (2012). Titanium as a reconstruction and implant material in
dentistry: advantages and pitfalls. Materials, 5(12):1528-1545. DOI: 10.3390/ma5091528
Materials 2012, 5, 1528-1545; doi:10.3390/ma5091528 
 
materials 
ISSN 1996-1944 
www.mdpi.com/journal/materials 
Review 
Titanium as a Reconstruction and Implant Material in Dentistry: 
Advantages and Pitfalls 
Mutlu Özcan * and Christoph Hämmerle  
Center for Dental and Oral Medicine, Clinic for Fixed and Removable Prosthodontics and Dental 
Materials Science, University of Zurich, Plattenstrasse 11, Zurich 8032, Switzerland;  
E-Mail: christoph.hammerle@zzmk.uzh.ch 
* Author to whom correspondence should be addressed; E-Mail: mutluozcan@hotmail.com;  
Tel.: +41-44-634-5600; Fax: +41-44-634-4305. 
Received: 14 June 2012; in revised form: 10 August 2012 / Accepted: 11 August 2012 /  
Published: 24 August 2012 
 
Abstract: Commercial pure titanium (cpTi) has been the material of choice in several 
disciplines of dentistry due to its biocompatibility, resistance to corrosion and mechanical 
properties. Despite a number of favorable characteristics, cpTi as a reconstruction and oral 
implant material has several shortcomings. This paper highlights current knowledge on 
material properties, passive oxidation film formation, corrosion, surface activation, cell 
interactions, biofilm development, allergy, casting and machining properties of cpTi for 
better understanding and potential improvement of this material for its clinical applications. 
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1. Introduction 
Since the 1960s, titanium has become a popular metallic biomaterial because of its properties for 
many biomechanical applications including dentistry. Although there is an increasing trend for  
metal-free restorations in the dental profession, failures in the form of fracture or chipping associated 
with such materials are still being reported [1] indicating that there is still place for the indication of 
metal-ceramic fixed-dental-prosthesis (FDP). Furthermore, extensive oral rehabilitations could only be 
achieved with metal-ceramic FDPs since flexural strength of glassy matrix or oxide-based all-ceramic 
restorations do not allow for durable constructions of multiple-unit restorations [2]. On the other hand, 
the use of titanium as an implant material has become an integral part of dental therapy. The high cost 
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of noble alloys and the potential biological hazards of the base metal alloys, were the main reasons for 
the introduction of commercially pure titanium (cpTi) and some of its alloys for the construction of 
dental prostheses and oral implants [3]. cpTi has been used in dentistry for more than five decades but 
there still seems to be potential to improve this material and its processing techniques in order to avoid 
possible biomechanical or biological complications. This paper will focus on current knowledge on 
cpTi and recent attempts to better understand and modify this material. 
2. Material Properties of Titanium 
Titanium is often used either as the pure metal, or in an alloyed form in aerospace applications, and 
in medical and dental work. It is commonly alloyed with other metals such as Vanadium (V) and 
Aluminum (Al). It forms then light-weight but at the same time strong alloys for the fabrication of oral 
implants or the frameworks for FDPs [2].  
According to the American Society of Testing Materials (ASTM), cpTi is available in four different 
grades (Grade I-IV) that is based on the incorporation of small amounts of oxygen, nitrogen, hydrogen, 
iron and carbon during purification procedures, where each grade has different physical and 
mechanical properties. Grades I and II are the most commonly used cpTi types for the production of 
metal-ceramic FDPs [3]. In oral implants and implant-supported FDPs, cpTi and its alloys exhibit 
remarkable advantages due to their excellent biocompatibility, corrosion resistance, high strength, and 
low modulus of elasticity [3]. Yet, the recent trends in making dental biomaterials more biomimetic 
from both biomechanical and biological perspectives, also applied for cpTi. 
Principally, the stress transfer between a metal framework and the dental tissues or bone is not 
homogeneous since stiffness (Young’s moduli) of the metal framework or implants and such tissues 
are different. This phenomenon is described as “stress shielding” [4]. In order to avoid devitalization 
of the tooth and atrophy in the bone under chewing function [5], high Young’s modulus of cpTi 
compared to those of the tooth and the bone structures, is not desirable. Young’s moduli of the most 
widely used SUS316L stainless steel and Co-Cr for orthopaedic implant devices, are approximately 
180 GPa and 210 GPa, respectively [6] whereas Young’s moduli of cpTi and its alloys are generally 
lower than those of stainless steels and Co-Cr alloys. For example, cpTi and its alloy, Ti-6Al-4V, 
which is widely used for constructing implant devices, have a Young’s modulus of around 110 GPa. 
The growth of fibrous connective tissue on the implant surface is an important aspect to consider in 
order avoiding complications. Fibrosis can interfere with healing of the damage created during implant 
surgery [2]. In that respect, Ti-6Al-4V produce very little fibrous tissue and therefore bone can grow 
easily. However, this value still remains to be higher than that of the bone (10–30 GPa),  
enamel (80 GPa) and dentin (20 GPa) [7]. For this reason, attempts are being made to modify alloying 
cpTi without sacrificing from its mechanical properties. 
cpTi alloys are generally classified as α-, (α + β)-, and β-type alloys. Young’s moduli of α- and  
(α + β)-type titanium alloys such as Ti and Ti-6Al-4V are higher than those of β-type titanium alloys. 
Generally, α-phase titanium is stronger but less ductile and β-phase titanium is more ductile.  
(α + β)-type titanium has mechanical properties which is in between both [5]. Therefore, β-type 
titanium alloys are considered more advantageous for the development of titanium alloys with low 
Young’s modulus for biomedical applications. Research lately has been focusing on reducing Young’s 
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moduli of β-type titanium alloys for use in biomedical applications. A number of β-type titanium 
alloys, mainly composed of toxicity- and allergy-free elements and with low Young’s moduli have 
been developed over the years and are still being developed [8]. β-type titanium alloys have usually 
Young’s moduli of approximately below 80 GPa treated in special solutions [9]. Young’s modulus of a 
material can be different depending on the type of measurement methods used, such as tensile tests, 
three-point bending tests, and free resonance methods. The lowest value of Young’s modulus reported 
for the polycrystal β-type titanium alloy, Ti-35Nb-4Sn [10] or Ti-24Nb-4Zr-7.9Sn [11], subjected to 
severe cold working, is around 40 GPa. Among β-type titanium alloys, Ti-29Nb-13Ta-4.6Zr (Daido 
Steel Co., Ltd., Nagoya, Japan), referred to as TNTZ, has a low Young’s modulus of 60 GPa when 
subjected to solution treatment and measured by a resonance method [9]. This value was even 
decreased to around 55 GPa while keeping the tensile strength stable by severe cold rolling and cold 
swaging [8] such as high pressure torsion, accumulative roll-bonding, and equal channel angular 
pressing [12]. Improving static strength such as tensile strength can be achieved by employing 
strengthening mechanisms by means of work hardening, grain refinement strengthening, precipitation 
strengthening, and dispersion strengthening [8].  
The strength as well as Young’s modulus of titanium alloys is a very important material property 
for their long-term durability when used as implants for biomedical applications. In particular, 
dynamic strength under fatigue conditions is highly important. Increasing the fatigue strength and 
simultaneously decreasing Young’s modulus is somewhat difficult because they are opposite natures 
when the forces between atomic arrangements are considered [5]. The fatigue strength of cpTi is 
significantly improved over the years by conducting aging treatment after solution treatment or 
thermo-mechanical processing including severe cold working followed by aging treatment. The 
addition of small amount of ceramic particles in the matrix is also expected to improve the fatigue 
strength of β-type titanium alloys while maintaining low Young’s modulus. Young’s modulus of 
TNTZ, for instance with Y2O3 addition, subjected to severe cold rolling is nearly constant at around  
60 GPa and it increases as a function of increased Y concentration. Relationships between tensile 
strength and elongation of TNTZ added with different amounts of Y2O3 addition, subjected to severe 
cold rolling showed excellent balance [13].  
The effect of Young’s modulus on bone atrophy and bone remodeling has been widely investigated 
using implants made of titanium alloys with different Young’s moduli [14]. The challenge remains as 
the simultaneous improvement of the dynamic strength and lowering Young’s modulus of the β-type 
titanium alloy, TNTZ. Of course, not only the material property as such but also the geometry of the 
reconstruction plays a major role to control Young’s modulus. Fortunately, as an oral implant material, 
clinical studies demonstrated limited failures in the implant material itself [15]. cpTi as an FDP 
framework material veneered with ceramics has not been evaluated long term in clinical studies. 
However, in general metal failures, regardless of the type of metal framework, perhaps with the 
exception of extreme bruxism cases, is a rarely experienced failure type in dentistry. Nevertheless, 
stress shielding between the reconstruction and the dental tissues, the biological response of the dental 
tissues and bone needs to be proved especially with new-alloyed titanium materials. 
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3. Passive Surface Oxide Film on Titanium  
Corrosion processes cause a reaction film to form on metallic materials. Certain metals like Ti 
oxidize easily, forming a very thin, stable passive layer that is self-limiting and protects the surface of 
the metal from further oxidation. Due to the tremendously fast rate at which they are formed, passive 
films, which are 1 to 5 nm thick, readily become amorphous [16]. The surface of oxide reacts with 
moisture in air and hydroxyl groups are rapidly formed within 30 ms. In the case of Ti, the surface 
oxide immediately reacts not only with water molecules in aqueous solutions but also with moisture in 
air and is covered by hydroxyl groups [16]. The surface hydroxyl groups contain both terminal OH and 
bridge OH in equal amounts. The surface oxide contains a hydroxide or hydroxyl group (OH) and 
water. This behavior, passivity, gives Ti its high corrosion resistance under certain controlled 
conditions where, otherwise, it would undergo strong active corrosion. The passive oxide layer formed 
on the surface of Ti is also considered responsible for its good biological performance, as it is less 
reactive than bare Ti [17]. Since amorphous films hardly contain grain boundaries or structural defects, 
they are usually corrosion resistant. However, corrosion resistance decreases with crystallization [17]. 
Metals can have stable passivity, where the oxide layer self-heals immediately after being ruptured, 
or they may present unstable passivity, where the oxide layer is unable to heal after disruption and the 
bare metal is exposed to active corrosion [18]. Both of these events depend on the oxidizing or 
reducing potential of the environment. On the other hand, active surface hydroxyl groups dissociate in 
aqueous solutions and form electric charges. Positive or negative charge due to the dissociation is 
governed by the pH of the surrounding aqueous solution where the positive and negative charges are 
balanced and the apparent charge is zero at a certain pH. This pH is the point of zero charge (pzc) [18]. 
The pzc is the unique value for an oxide and an indicator that the oxide shows acidic or basic 
properties. For example, in the case of TiO2, the pzc of rutile is 5.3 and that of anatase is 6.2 [18]. In 
other words, the anatase surface is acidic at lower pH and basic at higher pH than 6.2. Active surface 
hydroxyl groups and electric charges formed by the dissociation of the groups play important roles in 
the bonding with polymers and immobilization of molecules. 
4. Corrosion and Clinical Relevance  
Most materials chosen for prosthetic applications exhibit passivity properties and, thus, relatively 
low corrosion rates compared with those of other more reactive metals, such as Zinc, Magnesium, or 
Vanadium, which undergo active corrosion even in relatively neutral pH [19]. In the oral environment, 
extreme acidic conditions do not exist but the constant aqueous environment coupled with the biofilm 
effect, fatigue forces and possible interaction with other metals in the mouth may impair the passive 
surface oxide film [19]. Such environmental conditions can breach the protective oxide layer formed 
on the surfaces of these passive materials and cause corrosion, affecting the mechanical integrity of the 
implant and the health of the surrounding tissue. Extreme acidic conditions found during  
inflammation [19], fretting between implant and bone [20], and galvanic corrosion between Ti 
implants and other metallic alloys used for common dental procedures could greatly affect the 
mechanical stability and clinical outcome [21]. Eventually, implant surface properties such as 
roughness, chemistry, and energy directly influences tissue response by affecting protein adsorption 
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and modulating cell proliferation and differentiation [22]. Additionally, innovations in surface 
modification techniques have improved the biological performance of metallic implants [23,24]. 
However, some modifications may diminish mechanical properties of the bulk material, resulting in 
surface micro-cracks, increased corrosion rates [25,26], and, thus, increased corrosion currents that 
may affect surrounding cells and tissues. 
Corrosion of metallic implants, a topic extensively discussed in orthopedic literature, may 
jeopardize the mechanical stability of the implant and the integrity of the surrounding tissue [27,28]. 
Implant failure in the form of aseptic loosening, or osteolysis, may result from metal release in the 
form of wear debris or electrochemical products generated during corrosion events [29,30]. Metal ions 
such as Ti4+, Co2+, and Al3+ have been shown to decrease DNA synthesis, mitochondrial 
dehydrogenase activity, mineralization, and mRNA expression of alkaline phosphatase and osteocalcin 
in ROS 17/2.8 cells [31]. Similarly, phagocytosis of Ti particles caused cytotoxicity in a  
concentration-dependent manner in rat calvarial osteoblasts and MG63 cells [32,33].  
While implant loosening is less prominent in the dental literature, metal traces originating from 
dental implants have been found in blood, liver, lungs, and lymph nodes [34–36]. These metal ions and 
wear debris may also contribute to aseptic loosening by promoting inflammatory complications that 
may result in macrophage activation, bone resorption, and, rarely, in the potential development of 
neoplasia [37]. In 2006, titanium dioxide (TiO2) was classified as possibly carcinogenic to human 
beings (i.e., group 2B) at the International Agency for Research on Cancer (IARC) [38]. Animal 
studies in rodents provided sufficient evidence of the carcinogenic effects of TiO2, although 
epidemiological cohort studies in humans were inconclusive. Furthermore, the immediate and systemic 
cytotoxic and neoplastic effects of corrosion remain controversial because of conflicting studies that 
have found no effects of Ti ions or Ti particles on cells [39]. Moreover, the nanograms of metal per 
gram of tissue found in vivo [40] are difficult to compare with the micrograms and milligrams of metal 
per milliliters of solution used to create an effect in in vitro studies [32,33].  
The electrical implications of corrosion and its effect on the surrounding tissue may be an important 
aspect to focus in future studies, but such effects still remain unclear. Corrosion events generate 
electrical currents due to electron transfer from ions in the solution or to the metallic surface where 
reactions are occurring. These abnormal currents, and coupled electrical potentials, are directly related 
to the cyclic loads applied to the implant [28]. As described previously, bone cells are sensitive to 
electrical signals and, thus, could be strongly affected by these corrosion currents [19]. Moreover, 
these abnormal electrical signals may provide an alternate explanation for the unresolved causes of 
inflammatory complications and eventual aseptic loosening.  
With the growing popularity of treatments like early implant loading, it is imperative to consider the 
effects of electrical signals on the early stages of osseointegration as well as on long-term outcome. 
The concern of reducing implant corrosion might be addressed by new formulations of metallic alloys 
that improve the mechanical and corrosion properties of the implant [41,42], surface modifications that 
stabilize the reactivity of the surface [25] or electrical protection of implants. In particular, clinical 
implant failures, be it due to peri-implantitis or other reasons, need closer investigation of the material 
surface properties. 
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5. Titanium Surface Activation  
The use of bone-anchored titanium implants has become routine treatment modalities in dentistry. 
Apart from surgical procedures, the success of implants is highly dictated by the surface properties of 
the implant material that influence molecular interactions, cellular response and thereby, bone 
regeneration. Mesenchymal stem cell involvement, cell-cell communication at the bone-implant 
interfaces and in particular interactions between the surface oxide and the biological host are the 
underlying mechanisms of osseointegration.  
Titanium implants, machined to a smooth surface texture, has been used more than 50 years 
clinically. Over the years chemical and topographical modifications moderately changed surface 
topography. Evidence from in vitro and in vivo studies suggests that surface modifications on titanium 
implants promote a more rapid bone formation than do machined surfaces [43]. Ultrastructural 
modifications such as using ultrathin calcium phosphate coatings provide bonding on the atomic scale 
between the oxide and apatite nanocrystals [44]. Chemical and biological interactions between the 
coated titanium surface and the host tissue start with binding of water molecules, ions and 
biomolecules, followed by mineralization at the implant surface. Therefore, the initial state of the 
titanium surface is decisive for the tissue regeneration around the implant.  
Surface topography and surface roughness of oral implants have been modified from micro- to 
nanometer scales, which are partially dependent on the oxide or the bulk material. It is generally 
accepted that surface roughness on the micrometer scale plays an important role for cellular reactions, 
tissue healing and implant stability [45]. Different methods such as machining, air-abrasion, acid 
etching, electrochemical oxidation and laser treatment are used to alter surface topographies on 
titanium implant surfaces at various thicknesses.  
In anoxic acid media, complete dissolution of anodic oxide films on titanium can occur, leading to 
rapid corrosion [46]. Furthermore, these films on titanium are highly doped n-type semiconductors that 
grow via a high field growth mechanism and tend to be amorphous. The donors are believed to be Ti3− 
ions trapped in the process of migrating to the oxide-electrolyte interface, with the level of the donor 
density decreasing with increasing film formation rate. To circumvent these problems, typically the 
titanium implant surfaces are air-abraded with aluminum trioxide particles [47]. Blasted implants 
demonstrate better bone integration than turned/machined implants. In addition, blasted surface are 
also etched in some products. Different Ra/Sa values reported in the studies may be a result of 
different measurement equipments and evaluation techniques. In contrast to animal studies, clinical 
studies often fail to find any major advantages or disadvantages with blasted implants when compared 
with turned implants [47]. Nevertheless, after air abrasion, implant surfaces are coated with calcium 
phosphate/hydroxyapatite (HA). Initially, it was applied with plasma spraying by melting the coating 
material and spraying it onto the titanium surface. Early experience with these coatings suffered from 
adhesive debonding from the titanium surface or cracking. Later, evaporation coating such as physical 
vapor deposition (PVD) was tried where HA was sputtered onto the surface layer by layer that 
presented adequate adhesion on the titanium surface [48]. One limitation of this kind of coating is the 
surface geometry. Although it works ideally on flat surfaces, complex geometries could not be coated 
evenly using the PVD method. HA coatings were then tried to be applied using wet chemical processes, 
such as sol-gel technologies [49,50]. Although biological impact of such coatings is not  
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well-established, parameters such as immersion time, temperature, may affect the thickness, 
morphology and composition of the coatings.  
Covalently bonded, self-assembled monolayers such as silane coatings and thiols with different 
functional groups (i.e., methyl, hydroxyl or carboxyl groups) are also being tried to modulate the 
hydrophilicity of the titanium surface [51]. Peptide sequences have been used as monolayer 
modifications and shown to promote cell adhesion [52]. Recent attempts for activating titanium surface 
try to incorporate local release of pharmacological substances from the implant or graft material. One 
example is the use of bisphosphonates that downregulate osteoclast activity and result in more rapid 
bone regeneration around implants [53,54]. Although the clinical implication of monolayer modified 
implants remains to be verified, target oriented micro-, nano- or meso-scale features incorporating 
proteins or other biologically active substances seem to constitute future activation methods on 
titanium oral implants.  
6. Titanium-Cell Interactions  
Bone regeneration around oral titanium implants goes through stages of inflammation, regeneration 
and remodeling with possible overlap at all these phases. In the absence or presence of titanium 
implants both healing types show variations on the cellular and molecular level. In the presence of an 
implant, the implant itself acts as an osteoconductive substrate decreasing the size of the defect to be 
bridged by the new tissues. The titanium implant surface influences the initial sequences of protein 
adsorption, platelet adhesion, haemostasis, inflammation and osteogenic cell response [55–57]. In that 
respect, physico-chemical properties of the implant surface interacting with the cellular pheno- and 
genotypes at the immediate vicinity of the surface, molecular mechanism of how and in which 
sequence the cells are recruited and become adherent to the surface has to be defined. Moreover, the 
cell-cell communication during the early phase of osseointegration requires better understanding.  
Immunohistochemistry and SEM analysis show gene expression of cells adherent to titanium 
implants during the first hours and days after implantation [58,59] with higher expression of monocyte 
chemoattractant protein-1 (MCP-1) coupled with higher expression of pro-inflammatory cytokines 
TNF-a (3 h and 1 day after implantation) and IL-1b (1 day and 6 days after implantation) at machined 
implant surfaces. On the other hand, the expression of the chemokine receptor CXCR4, a receptor for 
stromal derived factor-1a (SDF-1a), was highly expressed at oxidized surfaces as early as 12 h after 
implantation. Coexistence of monocytes/macrophages and mesenchymal stem cells (MSCs) at the 
interfacial region with predominance of MSCs at the oxidized surface has been identified. It has been 
also shown that early peak expression of SDF-1a during the first day after tissue injury was associated 
with the highest MSCs at the injury site [60]. The role of SDF-1a/CXCR4 chemotactic axis in 
mediating the recruitment of progenitor cells is of current research interest to reveal the mesenchymal 
cell recruitment to different sites of healing [61].  
Cell attachment to the implant surface is one of the critical first steps in the cell response to a 
biomaterial [56]. The cellular attachment is mediated through a protein-rich layer through adhesion 
receptors including the integrins. Cells adherent to oxidized surfaces showed upregulation of  
integrin b1 during the 24 h of implantation [58,59]. In addition to osteogenic cells, monocytes and 
other cells also express integrin b1. Moreover, integrin b2, expressed mainly by leukocytes, was higher 
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at the oxidized implants after 12 h of implantation [61]. This integrin is also expressed by osteoclast 
progenitors [61]. 
Inflammation at the bone-implant interface has not received much attention as that given to the soft 
tissue-implant interface. Histological studies in bone revealed that macrophages and multinucleated 
cells are present in machined titanium implants [62] as well as HA-coated implants [63] during the 
early stage after implantation. These cells are known to express a wide range of pro-inflammatory and 
anti-inflammatory cytokines, growth and differentiation factors and chemotactic mediators. Major  
pro-inflammatory cytokine, TNF-a, was upregulated after 3 h at the machined implants compared with 
oxidized ones [58]. Higher expression was also observed at that surface after 1 day. Down regulatory 
effect was observed on the expression of IL-6 at titanium implants blasted with TiO2 particles and 
subsequently treated with hydrofluoric acid [64]. On the other hand, this surface was associated with 
higher expression of anti-inflammatory cytokine IL-10, eight weeks after implantation in rabbit 
cortical bone. Since many cell types, including osteoblasts, can express these cytokines and growth 
factors it is still important to define which cell type is responsible for these changes in gene expression. 
For instance, the expression of IGF-1 was also upregulated at HF surface during the eight-week 
evaluation period. In vitro studies have demonstrated that monocyte cell line expressed BMP-2 [65] 
that contributed principally to the osteogenic differentiation. However, in vivo data is not available 
showing the expression of BMP-2 from monocytes during osseointegration. Research based on 
antibody-labelling strategies such as immunohistochemistry and fluorescence assisted cell sorting are 
suggested to verify these findings [66].  
The regulation of gene expression at implant surfaces clinically is a complex phenomenon. The 
material properties possibly influence the gene expression by affecting transcription factor, such as 
RUNX2, in the differentiation of mesenchymal cells towards the osteoblastic lineage. This factor has 
also been shown to contribute to the osteoclastic differentiation [67]. The higher expression of 
osteoblast markers alkaline phosphatase (ALP) and osteocalcin (OC) and osteoclast marker  
cathepsin K (CATK) was parallel to a higher expression of RUNX2 at the oxidized surfaces compared 
with machined ones after 3 days of implantation [59]. Similar results were demonstrated for HF 
surface in comparison to surfaces without acid etching [59]. Although all of these studies suggest fast 
and strong influence of the different material surface properties on the expression of critical switching 
factors, it is still not revealed in which way and which specific surface properties contribute to  
such effects.  
Recent studies on early osseointegration (hours-days) have demonstrated that the upregulation of 
genes responsible for bone formation ALP and OC was coupled with upregulation of genes expressed 
by osteoclasts indicating that the bone remodeling phase is triggered much earlier than what has 
previously been assumed [59]. An intimate communication is established between osteogenic cells and 
osteoclasts. For instance, the surface receptor RANK on osteoclasts recognizes and binds to osteoblast 
membrane-associated factor (RANKL) during the osteoclastic differentiation from the monocytic 
lineage [68]. Briefly, active bone resorption and bone formation takes place starting already during the 
first days after implantation and continuing over time. Studies evaluating the gene expression of 
interfacial cells in combination with other surface properties of the implants are needed in order to 
extrapolate possible changes at implant-tissue interface, taking also coating or oxide stability on 
titanium surface into account. 
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7. Titanium-Biofilm Interactions  
The implant surface is susceptible to infection because of two main reasons, namely formation of a 
surface biofilm and compromised immune ability at the implant/tissue interface. The biocompatibility 
of titanium implant can be attributed to a surface protein layer formed under physiological  
conditions [69]. This protein layer actually makes the surface suitable for bacterial colonization and 
biofilm formation [70–72]. Biofilms are defined as a microbially derived sessile community 
characterized by cells irreversibly attached to a substratum, interface or to each other, embedded in a 
matrix of extracellular polymeric substances that they have produced, and exhibiting an altered 
phenotype with respect to growth rate and gene transcription [73]. Concerning the pivotal role that 
biofilm plays in implant-associated infections, the process of biofilm formation has been well 
documented [71–73]. The biofilm protects adherent bacteria from the host defense system and 
bactericidal agents via several proposed mechanisms [74]. The host immunity ability on the implant is 
consequently impaired. In the early phase after implantation, the local defense system is severely 
disturbed by the surgical trauma, and so it is the most dangerous time for infection. Even after 
completion of tissue integration, the defense ability at the implant/tissue interface is still compromised 
on account of the small number of blood vessels in this zone [69]. The reduced defense mechanism 
facilitates colonization of bacteria and infection may result. Although various measures such as 
thorough disinfection and stringent aseptic surgical protocols have been proposed to mitigate bacterial 
contamination, there is still evidence that bacterial invasion usually occurs after surgery [75]. Bacterial 
contamination can also arise from hematogenous sources at a later time [76]. Measurement of the 
water contact angle shows a nominal increase in the hydrophilic nature of TiO2 films, whereas the 
surface energy increases with decreasing contact angle [69]. Bacterial species Staphylococcus aureus 
and Escherichia coli interaction with nanostructured surfaces showed an increase in adhesion and 
biofilm formation with increasing nanoscale morphological properties [69].  
Research in this field tried using chlorhexidine that can adsorb to the TiO2 layer on the titanium 
surface and desorb gradually over a period of several days [77,78]. Several kinds of coatings fabricated 
on titanium with and without chlorhexidine adsorption were studied [79,80]. The chlorhexidine release 
pattern is similar to that of antibiotic coatings with an initially rapid release rate followed by a period 
of slower but sustained release [79]. Chlorhexidine can also adsorb onto the titanium implant surface 
modified by the covalent coupling of collagen on a polyanionic acrylic acid overlayer via the ionic 
interaction between the cationic chlorhexidine and polyanionic collagen surface [81]. Other alternative 
methods have also been employed to form coatings comprising non-antibiotic organic antimicrobial 
agents on titanium [82].  
More recent studies are trying to tune the TiO2 by using novel facile nanosphere colloidal 
lithographic technique in combination with biomolecular patterning [83,84].  
8. Titanium Allergy  
It should be noted that no material can be considered universally biocompatible and this does not 
exclude titanium [85]. It is recognized that environmental factors are contributing to the increase in the 
frequency of allergic disorders affecting world populations [86]. Dental biomaterials release 
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substances that alter the oral environment to a varying degree [87,88] and thus may contribute to local 
allergic reactions within the oral tissues. In the oral cavity, an elevated concentration of metal ions may 
be harmful and act as a local immuno-suppressant [89]. Recently, it has been suggested that titanium 
hypersensitivity may be a factor responsible for implant failure [90–92]. Although titanium 
hypersensitivity is a growing concern, epidemiological data on the incidence of titanium-related 
hypersensitivity reactions are still lacking.  
Degradation products of metallic biomaterials including titanium may mediate metal 
hypersensitivity or allergic reactions [93]. Titanium and other elements released from titanium 
implants have been observed in tissues and organs near implants [94]. The cause of ion release other 
than wear and fretting from titanium is unclear. Released titanium debris or ions may combine with 
biomolecules such as native proteins or form a protein-metal complex and become immunogenic, 
eliciting a Type-IV T-cell mediated response [95]. Even though titanium has been regarded as an inert 
metal, several earlier studies have identified potential hematologic and metabolic toxicity [85]. Reports 
relating to titanium toxicity are sparse but concur that cationic titanium and soluble titanates are 
relatively non-toxic in the amounts and forms that are normally ingested, due to poor absorption from 
the mammalian alimentary tract [85]. Furthermore, it seems possible that the incidence of allergic 
reaction to titanium implants may be under-reported due to a lack of recognition as a possible 
etiological factor in implant failure. Long-term clinical and radiographic follow-up of patients who 
have had an implant and who are diagnosed with metal sensitivity needs to be documented. At present, 
little is known on titanium hypersensitivity, but it cannot be excluded as a reason for implant or 
reconstruction failure.  
9. Dental Titanium Casting  
Despite the favorable characteristics, cpTi casting for prosthetic purposes has not been viable for 
many years since casting procedures led to the formation of an undesirable crust resulting in high 
reactivity and fragility [96]. This coating is called “alpha-case” and is formed by incorporation of the 
elements from the investment that may impair the adhesion between cpTi and ceramics for FDPs [97]. 
In order to allow the utilization of titanium, specific equipments were developed for casting, refractory 
investments were manufactured that were different from the conventional silica-phosphate investments, 
and ultra-low temperature ceramics were produced to be able to fire them on cast cpTi [98]. Only then 
cpTi was indicated for the fabrication of removable and FPDs.  
Dental castings are made via pressure-vacuum or centrifugal casting methods [99]. The metal is 
melted using an electric plasma arc or inductive heating in a melting chamber filled with inert gas or 
held in a vacuum. The molten metal is then transferred to the refractory mold via centrifugal or 
pressure-vacuum filling. Casting technology using a centrifugal casting machine with induction 
heating housed in a vacuum chamber to cast titanium implants. It was not until around 1977, that 
experimental castings of titanium for crowns and partial denture frames were finally made by 
induction melting in vacuum. It was difficult to maintain consistency in titanium dental castings 
because of their inherently poor castability. Though titanium is economical, biocompatible and readily 
available, technologies for easier casting, machining, welding and veneering are still necessary. 
Oxidation during melting and casting and the reaction of the molten metal to the investment material 
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should be minimal. With the advancements in casting technologies, the alfa-case layer was controlled 
better by induction in an environment with inert atmosphere of argon or helium gas and with the use of 
refractory investments that contain oxides such as magnesium, yttrium and zirconium [100–102].  
The control of alfa-case layer still remains a problem. Kimura et al. [103] identified the presence of 
four layers after cpTi casting and the authors advocated removal of the two first layers before 
application of the ceramic layer. Elimination of the superficial layer is however performed by 
utilization of a carbide burs at low speed. Since this procedure is operator driven by the dental 
technicians in the laboratories, it can never be made sure that alfa-case layer is removed in a controlled 
fashion. The oxide layer formed on the surface of the melted cpTi alloys presents great chemical 
stability. However this layer, at the same time, could impair chemical reactions between the cpTi and 
the bonder ceramic components, weakening the cpTi-ceramic union. Moreover, oxide layer is often not 
adhered sufficient, present a porous form and therefore it has been previously shown that oxide layer 
itself or the interface between the oxide layer and the alloy was responsible for the metal-ceramic 
fractures [103–105]. Recently, the mean flexural strength values for the ceramic-gold alloy 
combination were found significantly higher than those of the ceramic-cpTi combination regardless of 
the fatigue conditions performed [106]. Microscopic analysis of the specimens after flexural strength 
test showed complete adhesive detachment of the ceramic from the cpTi frameworks exclusively, 
indicating the weakest interface of the assembly was still located between the cpTi framework and its 
oxide layer. For these reasons, other processing routes are being developed for cpTi. To date, however, 
there is limited clinical data available that compare the long-term success of titanium restorations with 
those made from more traditional metals [107,108]. Hence, the severity of the problem remains scarce. 
10. Dental Titanium Machining  
Dental implants generally are machined from billet stock of pure metal or alloy. Dental crowns and 
bridge frameworks are also possible to be machined from solid metal stock via computer-aided 
machining (CAM) [109]. Abrasive machining of titanium, however, is slow and inefficient, which 
greatly limits this approach. Another method for fabricating dental appliances is electric discharge 
machining, which uses a fabricated graphite die, often reproduced from the dental working die, to 
erode the metal to final shape via spark erosion [110]. Multiple dental prostheses can be machined 
using CAM systems but implementation of such devices is very expensive. For these reasons, the use 
of titanium for dental castings has not become a prevalent laboratory and clinical practice. Currently, 
to eliminate possible limitations in casting or machining, materials with low reactivity are used to 
prevent surface reaction with the molten metal, and materials with high setting expansion are used to 
compensate for the high casting shrinkage of titanium. Future CAM procedures are needed for easy 
handling and controlled oxide formation on the cpTi. 
11. Conclusions 
Both titanium and titanium alloys, based on their physical, chemical and biological properties, 
appear to be especially suitable for dental implants and prostheses. For the construction of endosseous 
implant devices, titanium and its alloys have become well-accepted and can be considered the 
materials of choice. Surface activation or tuning of titanium surfaces certainly will improve biological 
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integrity in compromised situations, increasing clinical service of implant therapies even further. 
Processing difficulties, however, have limited usefulness of titanium in fixed and removable prostheses 
in dentistry. For crown and bridge prostheses, dentists can consider titanium and its alloys as viable 
options to more traditional noble and base metal alloys, but careful selection of processing methods 
and laboratory skill are necessary to ensure success.  
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